LIVN supply chain intelligence for LivaNova PLC: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| HAEMONETICS-CORPORATION | HAEMONETICS-CORPORATION | 80% | LivaNova’s primary medical device competitors in the Cardiopulmonary and Neuromodulation product groups are Terumo Medical Corporation, Maquet Medical Systems, Medtronic plc, Haemonetics Corporation,… |
| MAQUET-MEDICAL-SYSTEMS | MAQUET-MEDICAL-SYSTEMS | 80% | LivaNova’s primary medical device competitors in the Cardiopulmonary and Neuromodulation product groups are Terumo Medical Corporation, Maquet Medical Systems, Medtronic plc, Haemonetics Corporation,… |
| MDT | Medtronic plc | 80% | Reciprocal relationship from MDT graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from MDT graph: Reciprocal relationship from LIVN graph: LivaNova’s primary medical device com… |
| MDT | Medtronic plc | 80% | LivaNova’s primary medical device competitors in the Cardiopulmonary and Neuromodulation product groups are Terumo Medical Corporation, Maquet Medical Systems, Medtronic plc, Haemonetics Corporation,… |
| NEUROPACE-INC | NEUROPACE-INC | 80% | LivaNova’s primary medical device competitors in the Cardiopulmonary and Neuromodulation product groups are Terumo Medical Corporation, Maquet Medical Systems, Medtronic plc, Haemonetics Corporation,… |
| SPECTRUM-MEDICAL-LIMITED | SPECTRUM-MEDICAL-LIMITED | 80% | LivaNova’s primary medical device competitors in the Cardiopulmonary and Neuromodulation product groups are Terumo Medical Corporation, Maquet Medical Systems, Medtronic plc, Haemonetics Corporation,… |
| TERUMO-MEDICAL-CORPORATION | TERUMO-MEDICAL-CORPORATION | 80% | LivaNova’s primary medical device competitors in the Cardiopulmonary and Neuromodulation product groups are Terumo Medical Corporation, Maquet Medical Systems, Medtronic plc, Haemonetics Corporation,… |
| INSP | Inspire Medical Systems, Inc. | 72% | Reciprocal relationship from INSP graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from INSP graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from INSP g… |
| NPCE | NeuroPace, Inc. | 72% | Reciprocal relationship from NPCE graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from NPCE graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from NPCE g… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| DISTRIBUTORS-AND-A-NON-GOVERNMENTAL-ORGANIZATION | DISTRIBUTORS-AND-A-NON-GOVERNMENTAL-ORGANIZATION | 90% | Two of LivaNova’s non-U.S. subsidiaries currently sell medical devices, including cardiopulmonary and neuromodulation products, to distributors and a non-governmental organization in Iran to support … |
| IRANIAN-GOVERNMENT | IRANIAN-GOVERNMENT | 80% | However, to the best of its knowledge at this time, LivaNova does not have any contracts or commercial arrangements with the Iranian government or other relevant entities. |
| INSP | Inspire Medical Systems, Inc. | 72% | Reciprocal relationship from INSP graph: coverage policies with all major national commercial payors. In terms of government program coverage, all seven MACs provide coverage of Inspire therapy when … |
| NPCE | NeuroPace, Inc. | 72% | Reciprocal relationship from NPCE graph: rgery or are unwilling to undergo a destructive surgical procedure and we compete primarily with two manufacturers of neuromodulation devices for the treatmen… |
| CADENCE-NEUROSCIENCE-INC | CADENCE-NEUROSCIENCE-INC | 62% | ring expense not allocated to segments. F-16 Note 5. Goodwill and Intangible Assets The following table presents LivaNova’s finite-lived and indefinite-lived intangible assets (in thousands): Decembe… |
| NOCTRIX-HEALTH-INC | NOCTRIX-HEALTH-INC | 62% | ring expense not allocated to segments. F-16 Note 5. Goodwill and Intangible Assets The following table presents LivaNova’s finite-lived and indefinite-lived intangible assets (in thousands): Decembe… |
| RAINBOW-MEDICAL-LTD | RAINBOW-MEDICAL-LTD | 62% | ring expense not allocated to segments. F-16 Note 5. Goodwill and Intangible Assets The following table presents LivaNova’s finite-lived and indefinite-lived intangible assets (in thousands): Decembe… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| LIVN-DEBT-10727 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2013-04-26. |
| LIVN-DEBT | Debt stack $343.4M | 90% | Market cache reports total debt of $343.4M. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| LIVN-OWNER-BARCLAYS-PLC | BARCLAYS PLC | 90% | 13F overlay lists BARCLAYS PLC as top holder; 297 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| ITGR | Integer Holdings Corporation | 100.00 | 2 | |
| MDT | Medtronic plc | 100.00 | 2 | ['supplier'] |
| INSP | Inspire Medical Systems, Inc. | 100.00 | 2 | ['customer', 'supplier'] |
| RAPP | Rapport Therapeutics, Inc. | 50.00 | 2 | |
| NYXH | Nyxoah SA | 36.29 | 1 | ['spend'] |
| NPCE | NeuroPace, Inc. | 36.29 | 1 | ['customer', 'supplier'] |